Celgosivir

This classification denotes a glucosidase inhibitor and antiviral agent with the molecular formula C12H21NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 895VG117HN, chemically known as mdl 28,574a but generally known as celgosivir, which bears US NIH Compound Identifier 60734. European Medicines Agency schedules Celgosivir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07435MIG. The term CELGOSIVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). CELGOSIVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Celgosivir under HS 29339990 and SITC 51577. As of Q4 2014, CELGOSIVIR remains the US FDA Preferred Term for this commodity. Celgosivir bears US NLM identifiers UMLS ID C0287304 and NCI Concept Code C79567. SMILES: CCCC(=O)O[C@H]1CN2CC[C@@H]([C@@H]2[C@H]([C@@H]1O)O)O.